NDM-1-Producing Acinetobacter baumannii from Algeria

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Apr 2012 English Publisher:American Society for MicrobiologyJournal:Antimicrobial Agents and Chemotherapy, volume 56, pages 2,214-2,215 (issn: 0066-4804, eissn: 1098-6596,

Copyright policy )Funded by:EC | TEMPOTEST-QC

Authors: Boulanger, A.; Naas, T.; Fortineau, N.; Figueiredo, S.; Nordmann, P.;

doi: 10.1128/aac.05653-11

NDM-1-Producing Acinetobacter baumannii from Algeria

- Summary
- Metrics

Abstract

Over the last decade, nosocomial infections with Acinetobacter baumannii have been described with an increasing trend toward multidrug resistance, mostly in intensive care units (ICUs) ([6][1], [9][2], [11][3]). The main mechanism of resistance to carbapenems in A. baumannii is the production of

Related Organizations

University of Paris
France
French Institute of Health and Medical Research
France
Assistance Publique -Hopitaux De Paris
France
Bicêtre Hospital
France
University of Paris-Saclay
France

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	45
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%